08 Oct Meet us at ASN Kidney Week 2019
Serum and plasma cystatin C measurement - a fast, easy and reliable estimation of renal function
Gentian at ASN Kidney Week 2019
We look forward to exhibit at ASN Kidney Week 2019 and we hope to see you in Washington, DC from November 7th to 9th to discuss cystatin C and kidney health.
Meet us at ASN Kidney Week 2019
visit us at booth #2133 – ASN Kidney week 2019
Gaute Tangen, Product Manager Cystatin C, and Shanyil Wickramasinghe, US Product Specialist, will be present at booth #2133 to tell you more about our cystatin C immunoassay and cystatin C in the clinical setting.
Want to know more? Book a meeting in advance through email@example.com
Book at meeting
Come and meet us at booth #2133 to learn more about our cystatin C immunoassays and how our products contribute to diagnostic efficiency.
Book a meeting in advance – fill out the form below:
Gentian Cystatin C Immunoassay – FDA510(k) cleared
The Gentian Cystatin C Immunoassay is ERM-DA471 and IFCC standardised. The Gentian Cystatin C Immunoassay is FDA510(k) cleared and also CE-marked.
The immunoassay is a Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of cystatin C in human plasma and serum samples. It performs in 10 minutes.
The Gentian Cystatin C Immunoassay is used on a wide range of clinical chemistry analysers with documented high inter instrument accuracy .
Interested in our Cystatin C immunoassay?
Learn more about cystatin C
AACC WEBINAR ABOUT BIOMARKERS IN CHRONIC KIDNEY DISEASE:
LEARN MORE ABOUT GENTIAN’S CYSTATIN C IMMUNOASSAY FOR PLASMA AND SERUM:
GET MORE INSIGHT TO CYSTATIN C. READ OUR FAQ SECTION:
INTERVIEW WITH DR. A. GRUBB – CYSTATIN C, GFR AND SPS:
 O.Z. Ismail, et al., 2017, http://dx.doi.org/10.1016/j.clinbiochem.2017.01.005
 Tangri N, et al Kidney Int 2011;79:471-7
 NCIC Clinical guideline (CG182) updated jan 2014 section 2.1 https://www.nice.org.uk/guidance/cg182/chapter/2-Implementation-getting-started
 Eckfeldt JH, et al. 2014 CYS Survey. Arch Pathol Lab Med 2015;139:888-93